111 related articles for article (PubMed ID: 2570592)
1. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
Zhang X; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
[TBL] [Abstract][Full Text] [Related]
4. Interaction of some 2-hydroxybenzylpiperidines with dopamine receptors.
Cardellini M; Claudi F; Perlini V; Balduini W; Cattabeni F; Cimino M
Farmaco Sci; 1987 Apr; 42(4):307-17. PubMed ID: 3595841
[TBL] [Abstract][Full Text] [Related]
5. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
[TBL] [Abstract][Full Text] [Related]
6. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
Plantjé JF; Daus FJ; Hansen HA; Stoof JC
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):180-2. PubMed ID: 6208489
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N-n-propyl-N-(2-arylethyl)-5-(1H-benzimidazol-2-thione)-eth ylamines and related compounds as potential dopaminergic ligands.
Soskic V; Dukić S; Dragović D; Joksimović J
Arzneimittelforschung; 1996 Aug; 46(8):741-6. PubMed ID: 9125270
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of N-n-propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine derivatives as dopamine receptor ligands.
Claudi F; Giorgioni G; Di Stefano A; Renò F; Balduini W
Drug Des Discov; 1992; 9(2):155-66. PubMed ID: 1296798
[TBL] [Abstract][Full Text] [Related]
9. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
10. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
[No Abstract] [Full Text] [Related]
11. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
Iorio LC; Barnett A; Leitz FH; Houser VP; Korduba CA
J Pharmacol Exp Ther; 1983 Aug; 226(2):462-8. PubMed ID: 6135795
[TBL] [Abstract][Full Text] [Related]
12. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
Gredal O; Nielsen M; Hyttel J
Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
Dragović D; Soskić V; Joksimović J
Pharmazie; 1995 Oct; 50(10):678-80. PubMed ID: 7501691
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103
[TBL] [Abstract][Full Text] [Related]
15. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
17. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
Zhang X; Segawa T
Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
[TBL] [Abstract][Full Text] [Related]
18. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
Saller CF; Salama AI
J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
[TBL] [Abstract][Full Text] [Related]
19. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
Gredal O; Nielsen M
J Neurochem; 1987 Feb; 48(2):370-5. PubMed ID: 3491877
[TBL] [Abstract][Full Text] [Related]
20. Lateralization of neocortical dopamine receptors and dopamine level in normal Wistar rats.
Nowak G
Pol J Pharmacol Pharm; 1989; 41(2):133-7. PubMed ID: 2687822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
